{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:30:45Z","timestamp":1786113045609,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,9]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>The introduction of small-molecule tyrosine kinase inhibitors and immune checkpoint inhibitors has transformed therapeutic strategies for lung adenocarcinoma, significantly improving the survival of eligible patients. However, the prognosis remains poor for those lacking actionable driver mutations and presenting with brain metastases, who typically exhibit a median survival of &lt;6 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>After the initial resection (November 2016) and progression after adjuvant paclitaxel\/cisplatin chemotherapy, the patient developed brain and pulmonary metastases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Lung adenocarcinoma (cT3N0M1c, AJCC 8th edition) with synchronous brain and pulmonary metastases molecularly characterized as epidermal growth factor receptor- and anaplastic lymphoma kinase-negative.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>\n                      Complete remission was attained through a combined approach: whole-brain radiotherapy (WBRT) for intracranial lesions, CT-guided iodine-125 (\n                      <jats:sup>125<\/jats:sup>\n                      I) seed implantation for lung metastases, and maintenance bevacizumab (BEV).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>At the latest follow-up, the patient maintained complete remission for over 92 months, with a Karnofsky performance status of 100, demonstrating unprecedented long-term survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>\n                      This case demonstrates the potential synergistic efficacy of whole-brain radiotherapy,\n                      <jats:sup>125<\/jats:sup>\n                      I brachytherapy, and antiangiogenic therapy in advanced epidermal growth factor receptor\/anaplastic lymphoma kinase wild-type lung adenocarcinoma, providing a novel salvage strategy for chemotherapy-refractory metastatic disease. Prospective clinical trials are warranted to validate the survival benefits of this multimodal approach in molecularly unselected, high-risk populations.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000047018","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:03:25Z","timestamp":1767989005000},"page":"e47018","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Sustained complete remission in chemotherapy-refractory advanced lung adenocarcinoma with bevacizumab and iodine-125 seed implantation: A long-term case report"],"prefix":"10.1097","volume":"105","author":[{"given":"Dan","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Traditional Chinese Medicine, The Affiliated Dongguan Songshan Lake Central Hospital, Guangdong Medical University, Dongguan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuo","family":"Jin","sequence":"additional","affiliation":[{"name":"Sterilization and Supply Department, Huangshi Central Hospital, Huangshi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Air Force Medical Center, Air Force Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaochao","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Oncology, Huangshi Traditional Chinese Medicine Hospital, Huangshi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7027-7166","authenticated-orcid":false,"given":"Enfeng","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Renmin Hospital of Wuhan University, Wuhan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260805","first-page":"47","article-title":"Cancer incidence and mortality in China, 2022.","volume":"4","author":"Han","year":"2024","journal-title":"J Natl Cancer Cent"},{"key":"R2-20260805","doi-asserted-by":"crossref","first-page":"e459","DOI":"10.1016\/S1470-2045(22)00387-4","article-title":"Evolution of the joint International Atomic Energy Agency (IAEA), International Agency for Research on Cancer (IARC), and WHO cancer control assessments (imPACT Reviews).","volume":"23","author":"Veljkovikj","year":"2022","journal-title":"Lancet Oncol"},{"key":"R3-20260805","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer.","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"key":"R4-20260805","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.mayocp.2019.01.013","article-title":"Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment.","volume":"94","author":"Duma","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"R5-20260805","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/513S2a","article-title":"Epidemiology: the dominant malignancy.","volume":"513","author":"Bender","year":"2014","journal-title":"Nature"},{"key":"R6-20260805","doi-asserted-by":"crossref","first-page":"e454","DOI":"10.1002\/onco.13590","article-title":"2020 innovation-based optimism for lung cancer outcomes.","volume":"26","author":"Schenk","year":"2021","journal-title":"Oncologist"},{"key":"R7-20260805","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/neuonc\/nox077","article-title":"Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study.","volume":"19","author":"Cagney","year":"2017","journal-title":"Neuro Oncol"},{"key":"R8-20260805","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.radonc.2008.05.020","article-title":"A phase III study of accelerated versus conventional hypofractionated whole brain irradiation in patients of good performance status with brain metastases not suitable for surgical excision.","volume":"88","author":"Davey","year":"2008","journal-title":"Radiother Oncol"},{"key":"R9-20260805","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/00207454.2021.1916490","article-title":"Stereotactic radiosurgery with whole brain radiotherapy combined with bevacizumab in the treatment of brain metastases from NSCLC.","volume":"133","author":"Li","year":"2023","journal-title":"Int J Neurosci"},{"key":"R10-20260805","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1515\/med-2020-0192","article-title":"Bevacizumab for non-small cell lung cancer patients with brain metastasis: a meta-analysis.","volume":"15","author":"Liang","year":"2020","journal-title":"Open Med (Wars)"},{"key":"R11-20260805","doi-asserted-by":"crossref","first-page":"540096","DOI":"10.3389\/fonc.2020.540096","article-title":"Long-term outcomes and prognostic analysis of computed tomography-guided radioactive 125I seed implantation for locally recurrent rectal cancer after external beam radiotherapy or surgery.","volume":"10","author":"Wang","year":"2021","journal-title":"Front Oncol"},{"key":"R12-20260805","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3389\/fonc.2020.00470","article-title":"Oligorecurrence non-small cell lung cancer after failure of first-line chemotherapy: computed tomography-guided 125I seed implantation vs. second-line chemotherapy.","volume":"10","author":"Wang","year":"2020","journal-title":"Front Oncol"},{"key":"R13-20260805","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.ijrobp.2009.12.010","article-title":"Improved intratumoral oxygenation through vascular normalization increases glioma sensitivity to ionizing radiation.","volume":"76","author":"McGee","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R14-20260805","doi-asserted-by":"crossref","first-page":"bcr2013201554","DOI":"10.1136\/bcr-2013-201554","article-title":"The CARE guidelines: consensus-based clinical case reporting guideline development.","volume":"2013","author":"Gagnier","year":"2013","journal-title":"BMJ Case Rep"},{"key":"R15-20260805","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1007\/s12094-017-1673-7","article-title":"Validation of the prognostic value of new sub-stages within the AJCC 8th edition of non-small cell lung cancer.","volume":"19","author":"Abdel-Rahman","year":"2017","journal-title":"Clin Transl Oncol"},{"key":"R16-20260805","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1007\/s11095-023-03595-w","article-title":"An update on potential molecular biomarkers of dietary phytochemicals targeting lung cancer interception and prevention.","volume":"40","author":"Peter","year":"2023","journal-title":"Pharm Res"},{"key":"R17-20260805","first-page":"192","article-title":"Prognostic and predictive biomarkers in non-small cell lung carcinoma.","volume":"56","author":"Odintsov","year":"2024","journal-title":"Pathology (Phila)"},{"key":"R18-20260805","doi-asserted-by":"crossref","first-page":"196","DOI":"10.21037\/tlcr.2017.03.01","article-title":"Current state of immunotherapy for non-small cell lung cancer.","volume":"6","author":"Malhotra","year":"2017","journal-title":"Transl Lung Cancer Res"},{"key":"R19-20260805","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1002\/ijc.35347","article-title":"How many people in the US are eligible for and respond to checkpoint inhibitors: an empirical analysis.","volume":"156","author":"Haslam","year":"2025","journal-title":"Int J Cancer"},{"key":"R20-20260805","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1016\/j.cllc.2018.01.007","article-title":"Non-small-cell lung cancer with brain metastasis at presentation.","volume":"19","author":"Waqar","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"R21-20260805","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41571-019-0320-3","article-title":"Current approaches to the management of brain metastases.","volume":"17","author":"Suh","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"R22-20260805","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.21037\/jtd.2019.10.49","article-title":"Efficacy and safety of bevacizumab combined with chemotherapy in symptomatic brain metastases from lung adenocarcinoma: a retrospective analysis.","volume":"11","author":"Zhan","year":"2019","journal-title":"J Thorac Dis"},{"key":"R23-20260805","doi-asserted-by":"crossref","first-page":"e6073","DOI":"10.1590\/1414-431x20176073","article-title":"Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer.","volume":"51","author":"Yang","year":"2017","journal-title":"Braz J Med Biol Res"},{"key":"R24-20260805","doi-asserted-by":"crossref","first-page":"340","DOI":"10.6004\/jnccn.2023.0020","article-title":"NCCN guidelines\u00ae insights: non-small cell lung cancer, version 2.2023.","volume":"21","author":"Ettinger","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"R25-20260805","doi-asserted-by":"crossref","first-page":"714006","DOI":"10.3389\/fendo.2021.714006","article-title":"Case report: successful control of pulmonary metastatic pheochromocytoma with iodine-125 seed implantation.","volume":"12","author":"Shi","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R26-20260805","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4103\/jcrt.jcrt_1660_21","article-title":"Analysis of the clinical efficacy and safety of computerized tomography-guided 125 I seed implantation in the treatment of non-small cell lung cancer that relapsed after chemoradiotherapy.","volume":"18","author":"Wang","year":"2022","journal-title":"J Cancer Res Ther"},{"key":"R27-20260805","first-page":"3753","article-title":"Clinical outcomes of radioactive seed brachytherapy and microwave ablation in inoperable stage I non-small cell lung cancer.","volume":"13","author":"Ji","year":"2023","journal-title":"Am J Cancer Res"},{"key":"R28-20260805","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13014-023-02264-x","article-title":"Efficacy and safety of particle therapy for inoperable stage II-III non-small cell lung cancer: a systematic review and meta-analysis.","volume":"18","author":"Chen","year":"2023","journal-title":"Radiat Oncol"},{"key":"R29-20260805","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10456-017-9552-y","article-title":"Anti-angiogenesis for cancer revisited: is there a role for combinations with immunotherapy?","volume":"20","author":"Ramjiawan","year":"2017","journal-title":"Angiogenesis"},{"key":"R30-20260805","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.brachy.2017.11.015","article-title":"Efficacy and safety of iodine-125 radioactive seeds brachytherapy for advanced non-small cell lung cancer-a meta-analysis.","volume":"17","author":"Zhang","year":"2018","journal-title":"Brachytherapy"},{"key":"R31-20260805","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3892\/ol.2025.14943","article-title":"Pan-immune-inflammatory values predict survival in patients after radical surgery for non-metastatic colorectal cancer: a retrospective study.","volume":"29","author":"Li","year":"2025","journal-title":"Oncol Lett"},{"key":"R32-20260805","doi-asserted-by":"crossref","first-page":"8902","DOI":"10.1038\/s41598-025-94126-7","article-title":"Prognostic value of combined NP and LHb index with absolute monocyte count in colorectal cancer patients.","volume":"15","author":"Wang","year":"2025","journal-title":"Sci Rep"},{"key":"R33-20260805","first-page":"104588","article-title":"Prognostic scoring system using inflammation- and nutrition-related biomarkers to predict prognosis in stage I-III colorectal cancer patients.","volume":"31","author":"Li","year":"2025","journal-title":"World J Gastroenterol"},{"key":"R34-20260805","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1007\/s12672-025-03068-z","article-title":"Single-cell RNA sequencing reveals TMEM71 as an immunomodulatory biomarker predicting immune checkpoint blockade response in breast cancer.","volume":"16","author":"Li","year":"2025","journal-title":"Discov Oncol"},{"key":"R35-20260805","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s12672-025-02811-w","article-title":"Integrative transcriptomic and single-cell analysis reveals IL27RA as a key immune regulator and therapeutic indicator in breast cancer.","volume":"16","author":"Chen","year":"2025","journal-title":"Discov Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T17:02:06Z","timestamp":1785949326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047018","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"2025-04-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}